RU2004122921A - Композиция для ингаляции - Google Patents
Композиция для ингаляции Download PDFInfo
- Publication number
- RU2004122921A RU2004122921A RU2004122921/15A RU2004122921A RU2004122921A RU 2004122921 A RU2004122921 A RU 2004122921A RU 2004122921/15 A RU2004122921/15 A RU 2004122921/15A RU 2004122921 A RU2004122921 A RU 2004122921A RU 2004122921 A RU2004122921 A RU 2004122921A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- composition according
- pvp
- peg
- amount
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
- Networks Using Active Elements (AREA)
- Pyrane Compounds (AREA)
Claims (12)
1. Фармацевтическая композиция, содержащая формотерол, будесонид, HFA 227, ПВП (поливинилпирролидон) и ПЭГ (полиэтиленгликоль).
2. Препарат по п.1, отличающийся тем, что ПВП присутствует в количестве от приблизительно 0,0005 до приолизительно 0,05 мас.%, а ПЭГ присутствует в количестве от приблизительно 0,05 до приблизительно 0,35 мас.%.
3. Фармацевтическая композиция по п.1, где ПВП представляет собой ПВП К25.
4. Фармацевтическая композиция по п.1, где ПВП присутствует в количестве 0,001 мас.%.
5. Фармацевтическая композиция по п.1, где ПЭГ представляет собой ПЭГ 1000.
6. Фармацевтическая композиция по п.1, где ПЭГ присутствует в количестве 0,3 мас.%.
7. Фармацевтическая композиция по п.1, где формотерол находится в форме его соли, представляющей собой фумарата дигидрат.
8. Фармацевтическая композиция по п.1, где формотерол находится в форме единственного R,R-энантиомера.
9. Фармацевтическая композиция по п.1, где второй активный ингредиент представляет собой 22R-эпимер будесонида.
10. Фармацевтическая композиция по п.1 для применения в лечении или профилактике респираторного заболевания.
11. Фармацевтическая композиция по п.1 для применения в лечении или профилактике астмы, ринита или ХОБЛ (хроническая обструктивная болезнь легких).
12. Способ лечения респираторного заболевания у млекопитающего, при котором пациенту вводят фармацевтическую композицию по любому из пп.1-9.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0200312A SE0200312D0 (sv) | 2002-02-01 | 2002-02-01 | Novel composition |
| SE0200312-7 | 2002-02-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2004122921A true RU2004122921A (ru) | 2005-06-10 |
| RU2301673C2 RU2301673C2 (ru) | 2007-06-27 |
Family
ID=20286853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2004122921/15A RU2301673C2 (ru) | 2002-02-01 | 2003-01-29 | Композиция для ингаляции |
Country Status (28)
| Country | Link |
|---|---|
| US (8) | US7759328B2 (ru) |
| EP (2) | EP2036549B1 (ru) |
| JP (2) | JP2005521663A (ru) |
| KR (2) | KR20090125857A (ru) |
| CN (1) | CN1287774C (ru) |
| AT (2) | ATE423552T1 (ru) |
| AU (1) | AU2003206289B2 (ru) |
| BR (1) | BR0307193A (ru) |
| CA (1) | CA2474479C (ru) |
| CO (1) | CO5611098A2 (ru) |
| CY (2) | CY1109030T1 (ru) |
| DE (2) | DE60332067D1 (ru) |
| DK (2) | DK1474117T3 (ru) |
| ES (2) | ES2342509T3 (ru) |
| HK (1) | HK1126684A1 (ru) |
| IL (1) | IL163160A (ru) |
| IS (2) | IS7360A (ru) |
| MX (1) | MXPA04007295A (ru) |
| NO (1) | NO337006B1 (ru) |
| NZ (1) | NZ534452A (ru) |
| PL (1) | PL211836B1 (ru) |
| PT (2) | PT1474117E (ru) |
| RU (1) | RU2301673C2 (ru) |
| SE (1) | SE0200312D0 (ru) |
| SI (2) | SI1474117T1 (ru) |
| UA (1) | UA79445C2 (ru) |
| WO (1) | WO2003063842A1 (ru) |
| ZA (1) | ZA200406086B (ru) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0200312D0 (sv) * | 2002-02-01 | 2002-02-01 | Astrazeneca Ab | Novel composition |
| BRPI0606736A2 (pt) * | 2005-02-11 | 2009-07-21 | Argenta Discovery Ltd | combinação de compostos e esteróides de metilxantina para tratar doenças respiratórias crÈnicas |
| US9084799B2 (en) | 2005-02-11 | 2015-07-21 | Pulmagen Therapeutics (Synergy) Limited | Inhaled combination therapy |
| DE102006053374A1 (de) * | 2006-02-09 | 2007-08-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz |
| GB0604141D0 (en) * | 2006-03-01 | 2006-04-12 | Arrow Int Ltd | Nebulizer formulation |
| GB0712454D0 (en) * | 2007-06-27 | 2007-08-08 | Generics Uk Ltd | Pharmaceutical compositions |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| US20130160761A1 (en) * | 2008-11-04 | 2013-06-27 | Cipla Limited | Pharmaceutical Aerosol Composition |
| NZ574666A (en) | 2009-02-05 | 2009-04-30 | Nexus6 Ltd | A medicament inhaler holder that uses optical means to count and display the number of doses used |
| EP2414560B1 (de) | 2009-03-31 | 2013-10-23 | Boehringer Ingelheim International GmbH | Verfahren zur beschichtung einer oberfläche eines bauteils |
| WO2010133294A2 (de) | 2009-05-18 | 2010-11-25 | Boehringer Ingelheim International Gmbh | Adapter, inhalationseinrichtung und zerstäuber |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| CN102686260B (zh) | 2009-11-25 | 2014-10-01 | 贝林格尔.英格海姆国际有限公司 | 喷雾器 |
| JP5658268B2 (ja) | 2009-11-25 | 2015-01-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| US9943654B2 (en) | 2010-06-24 | 2018-04-17 | Boehringer Ingelheim International Gmbh | Nebulizer |
| RU2568882C2 (ru) * | 2010-07-16 | 2015-11-20 | Сипла Лимитед | Фармацевтические композиции |
| CN103052378A (zh) * | 2010-08-03 | 2013-04-17 | 奇斯药制品公司 | 包含磷酸二酯酶抑制剂的药物制剂 |
| CA2812263A1 (en) * | 2010-09-22 | 2012-03-29 | Map Pharmaceuticals, Inc. | Corticosteroid particles and method of production |
| US20120204871A1 (en) | 2011-02-10 | 2012-08-16 | Julio Cesar Vega | Stable, non-corrosive formulations for pressurized metered dose inhalers |
| TWI399202B (zh) * | 2011-03-17 | 2013-06-21 | Intech Biopharm Ltd | 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法 |
| WO2012130757A1 (de) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| BR112014003907A2 (pt) | 2011-08-19 | 2017-06-13 | Intech Biopharm Ltd. | método para preparar inalador pulverizado de dose medida para tratar doença respiratória |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| ES2836977T3 (es) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizador |
| US9744313B2 (en) | 2013-08-09 | 2017-08-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
| GB201321717D0 (en) | 2013-12-09 | 2014-01-22 | Pharmachemie Bv | Inhalable Medicaments |
| GB201321712D0 (en) | 2013-12-09 | 2014-01-22 | Pharmachemie Bv | Dry Powder Inhaler |
| UA121114C2 (uk) | 2014-05-07 | 2020-04-10 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | Небулайзер, індикаторний пристрій і контейнер |
| EP3139979B1 (en) | 2014-05-07 | 2023-07-05 | Boehringer Ingelheim International GmbH | Unit, nebulizer and method |
| ES2874029T3 (es) | 2014-05-07 | 2021-11-04 | Boehringer Ingelheim Int | Nebulizador |
| US20170189329A1 (en) | 2014-07-29 | 2017-07-06 | 3M Innovative Properties Company | Method of preparing a pharmaceutical composition |
| EP3701940A1 (en) | 2015-12-04 | 2020-09-02 | Mexichem Fluor S.A. de C.V. | Pharmaceutical composition |
| CN106581010B (zh) * | 2016-12-28 | 2019-03-05 | 四川普锐特医药科技有限责任公司 | 一种气溶胶制剂及定量吸入气雾剂 |
| AU2018318123A1 (en) | 2017-08-15 | 2020-03-19 | Nephron Pharmaceuticals Corporation | Aqueous nebulization composition |
| JP7470646B2 (ja) | 2018-06-14 | 2024-04-18 | アストラゼネカ・ユーケイ・リミテッド | コルチコステロイド医薬組成物を用いて喘息の症状を治療および予防するための方法 |
| JP7402631B2 (ja) | 2018-08-27 | 2023-12-21 | 帝人株式会社 | 極細炭素繊維混合物、その製造方法、及び炭素系導電助剤 |
| CN109464429B (zh) * | 2018-12-13 | 2021-04-27 | 上海方予健康医药科技有限公司 | 一种吸入压力定量气雾剂药物组合物及其制备方法 |
| CN112137957B (zh) | 2019-06-26 | 2022-07-29 | 长风药业股份有限公司 | 一种药用吸入气雾剂及其制备方法 |
| CN112972384B (zh) * | 2019-12-02 | 2022-03-18 | 长风药业股份有限公司 | 一种格隆溴铵和茚达特罗原料药微粉混合物的制备方法 |
| CN117357485A (zh) * | 2023-11-01 | 2024-01-09 | 山东京卫制药有限公司 | 一种改良的可吸入的载体颗粒及应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL103238A (en) * | 1991-09-25 | 1995-07-31 | Fisons Plc | Pressed aerosol preparations |
| US6123924A (en) * | 1991-09-25 | 2000-09-26 | Fisons Plc | Pressurized aerosol inhalation compositions |
| DE69232462T2 (de) | 1991-12-18 | 2002-10-10 | Astrazeneca Ab | Formoterol und budesonide enthaltende zusammensetzung |
| DE19536902A1 (de) * | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
| SE9603669D0 (sv) | 1996-10-08 | 1996-10-08 | Astra Ab | New combination |
| WO1998021175A1 (en) * | 1996-11-11 | 1998-05-22 | Sepracor, Inc. | Process for the preparation of optically pure isomers of formoterol |
| SE9703407D0 (sv) * | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
| US6309623B1 (en) * | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
| SE9802073D0 (sv) * | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
| DE59911149D1 (de) | 1998-07-24 | 2004-12-30 | Jago Res Ag Muttenz | Medizinische aerosolformulierungen |
| US6004537A (en) * | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
| SE9900834D0 (sv) | 1999-03-09 | 1999-03-09 | Astra Ab | Novel combination |
| PE20011227A1 (es) * | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
| GB0009584D0 (en) | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Pharmaceutical compositions |
| GB0012260D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
| GB0016876D0 (en) | 2000-07-11 | 2000-08-30 | Astrazeneca Ab | Novel formulation |
| US20030018019A1 (en) * | 2001-06-23 | 2003-01-23 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics |
| SE0200312D0 (sv) * | 2002-02-01 | 2002-02-01 | Astrazeneca Ab | Novel composition |
-
2002
- 2002-02-01 SE SE0200312A patent/SE0200312D0/xx unknown
-
2003
- 2003-01-29 PT PT03703575T patent/PT1474117E/pt unknown
- 2003-01-29 PT PT08166881T patent/PT2036549E/pt unknown
- 2003-01-29 AU AU2003206289A patent/AU2003206289B2/en not_active Expired
- 2003-01-29 AT AT03703575T patent/ATE423552T1/de active
- 2003-01-29 DE DE60332067T patent/DE60332067D1/de not_active Expired - Lifetime
- 2003-01-29 NZ NZ534452A patent/NZ534452A/en not_active IP Right Cessation
- 2003-01-29 DE DE60326320T patent/DE60326320D1/de not_active Expired - Lifetime
- 2003-01-29 CA CA2474479A patent/CA2474479C/en not_active Expired - Lifetime
- 2003-01-29 EP EP08166881A patent/EP2036549B1/en not_active Expired - Lifetime
- 2003-01-29 ES ES08166881T patent/ES2342509T3/es not_active Expired - Lifetime
- 2003-01-29 UA UA20040806416A patent/UA79445C2/uk unknown
- 2003-01-29 BR BR0307193-6A patent/BR0307193A/pt not_active Application Discontinuation
- 2003-01-29 DK DK03703575T patent/DK1474117T3/da active
- 2003-01-29 PL PL372118A patent/PL211836B1/pl unknown
- 2003-01-29 US US10/502,685 patent/US7759328B2/en not_active Expired - Lifetime
- 2003-01-29 ES ES03703575T patent/ES2321180T3/es not_active Expired - Lifetime
- 2003-01-29 AT AT08166881T patent/ATE463241T1/de active
- 2003-01-29 SI SI200331563T patent/SI1474117T1/sl unknown
- 2003-01-29 DK DK08166881.6T patent/DK2036549T3/da active
- 2003-01-29 EP EP03703575A patent/EP1474117B1/en not_active Revoked
- 2003-01-29 SI SI200331805T patent/SI2036549T1/sl unknown
- 2003-01-29 CN CNB038031221A patent/CN1287774C/zh not_active Expired - Lifetime
- 2003-01-29 WO PCT/SE2003/000156 patent/WO2003063842A1/en active Application Filing
- 2003-01-29 KR KR1020097024298A patent/KR20090125857A/ko not_active Application Discontinuation
- 2003-01-29 KR KR1020047011787A patent/KR100947168B1/ko active IP Right Grant
- 2003-01-29 RU RU2004122921/15A patent/RU2301673C2/ru active
- 2003-01-29 JP JP2003563536A patent/JP2005521663A/ja not_active Withdrawn
-
2004
- 2004-07-21 IS IS7360A patent/IS7360A/is unknown
- 2004-07-22 IL IL163160A patent/IL163160A/en active IP Right Grant
- 2004-07-27 CO CO04071996A patent/CO5611098A2/es not_active Application Discontinuation
- 2004-07-28 MX MXPA04007295A patent/MXPA04007295A/es active IP Right Grant
- 2004-07-29 ZA ZA2004/06086A patent/ZA200406086B/en unknown
- 2004-08-19 NO NO20043458A patent/NO337006B1/no not_active IP Right Cessation
-
2009
- 2009-04-29 CY CY20091100471T patent/CY1109030T1/el unknown
- 2009-06-30 HK HK09105851.8A patent/HK1126684A1/xx not_active IP Right Cessation
-
2010
- 2010-02-26 JP JP2010041992A patent/JP5259636B2/ja not_active Expired - Lifetime
- 2010-05-28 US US12/790,196 patent/US8143239B2/en not_active Expired - Fee Related
- 2010-06-14 CY CY20101100546T patent/CY1110081T1/el unknown
-
2012
- 2012-03-05 US US13/411,939 patent/US8575137B2/en not_active Expired - Lifetime
-
2013
- 2013-04-16 IS IS9028A patent/IS2960B/is unknown
- 2013-10-18 US US14/057,548 patent/US20140286878A1/en not_active Abandoned
-
2015
- 2015-03-02 US US14/635,550 patent/US20160022703A1/en not_active Abandoned
-
2017
- 2017-02-08 US US15/427,425 patent/US10166247B2/en not_active Expired - Lifetime
-
2018
- 2018-08-22 US US16/108,368 patent/US20190216828A1/en not_active Abandoned
-
2020
- 2020-03-27 US US16/832,590 patent/US11311558B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2004122921A (ru) | Композиция для ингаляции | |
| ATE330589T1 (de) | Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege | |
| ES2792682T3 (es) | Métodos para el tratamiento de enfermedades pulmonares con estabilizadores de mastocitos | |
| RU2006132036A (ru) | Комбинация и фармацевтический препарат для лечения аллергий и заболеваний дыхательных путей | |
| JP2010132695A5 (ru) | ||
| JP2018199684A5 (ru) | ||
| HRP20130835T1 (hr) | Farmaceutske formulacije otopine za davanje kao stlaäśeni inhalat u inhalatoru | |
| ATE361077T1 (de) | Indanylderivate zur behandlung von atemwegserkrankungen | |
| JP2019517597A5 (ru) | ||
| RU2006132038A (ru) | Комбинация (варианты) и фармацевтический препарат для лечения заболеваний дыхательных путей | |
| JP2002104963A (ja) | 痛みの治療または予防のための吸入可能なエーロゾル薬剤 | |
| RU2006132040A (ru) | Комбинация (варианты) и фармацевтический препарат для лечения заболеваний дыхательных путей | |
| CA2409665A1 (en) | Novel composition | |
| JP2004525903A5 (ru) | ||
| DE69002718D1 (de) | Medikamente. | |
| JP2007524699A5 (ru) | ||
| ES2257282T3 (es) | Melagatran para el tratamiento de inflamacion. | |
| EA200701077A1 (ru) | Применение конъюгатов липидов при лечении заболеваний | |
| JP2005514440A (ja) | アミドおよび／またはエステルを含有する、賦形剤化合物を含む、医用エアロゾル組成物 | |
| RU2010120806A (ru) | Композиции для ингаляции, содержащие кислоту монтелукаст и ингибитор pde-4 или ингаляционный кортикостероид | |
| JP2005508963A5 (ru) | ||
| JP2005524666A5 (ru) | ||
| JP2009506029A5 (ru) | ||
| JP2019516797A5 (ru) | ||
| RU2008108176A (ru) | Комбинация соединений, которая может быть применена в лечении респеративных заболеваний, особенно хронического обструктивного заболевания легких (copd) и астмы |